Ursodeoxycholic Acid Powder (128-13-2) Nā kikoʻī
| Product Name | ʻAkika ursodeoxycholic |
| Hawaiian Name | (R)-4-((3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid |
| Sinimona | UDCA;
Ursodiol; Tauroursodiol;Urosodeoxycholic Acid; Ursodeoxycholic acid(micronized); URSODEOXYCHOLIC ACID; URSODESOXYCHOLIC ACID; URSODEOXYCHOLOC ACID; |
| Kāleka CAS | 128-13-2 |
| InChIKey | RUDATBOHQWOJDD-UZVSRGJWSA-N |
| hakakino F'Oula | C24H40O4 |
| hakakino Wʻewalu | 392.57 |
| Monoisotopic Mass | 392.29265975 |
| Point Hoʻolālā | 203-204 °C (kukui) |
| 'Ohiʻa Pʻo kaʻaila | 437.26 ° C (kūpono kūpono) |
| nuʻa | 0.9985 (kuhi kūpono) |
| kala like 'ole | Keʻokeʻo - aneane keʻokeʻo |
| Palekana | ethanol: 50 mg/mL, akaka |
| pūnaewele Tka mahana | 2-8 ° C |
| noi | ʻO ka Ursodeoxycholic acid (UDCS) kahi pale pale i hoʻohana nui ʻia e hoʻēmi i nā maʻi hepatic a me ka biliary. Hiki ke hoʻohana ʻia ka ursodeoxycholic acid e aʻo i kāna mau hana kikoʻī e pili ana i ka hoʻemi ʻana o ka cholesterol absorpition, cholesterol gallstone dissolution a hiki i ka hoʻopau ʻana i ka pane kūlohelohe. |
| Hōʻike hōʻike hōʻike | Available |
ʻO Ursodeoxycholic acid (UDCA), i ʻike ʻia ʻo Ursodiol, he ʻakika bile i huna ʻia i loko o ka wai bile. Ua ʻike mua ʻia i loko o ka bile o nā bea. ʻOiai ʻaʻole ia ka nui bile acid i loko o ke kanaka, ua ʻike ʻia he waiwai therapeutic koʻikoʻi. Hiki ke ʻike ʻia ka mōʻaukala o ka hoʻohana ʻana o UDCA i nā kānaka i ka wā kahiko ma Kina.
I kēia manawa, hoʻohana ʻia ka UDCA exogenous ma ka honua holoʻokoʻa e mālama a mālama i nā ʻano hepatobiliary like ʻole, e like me nā maʻi gallstone (cholelithiasis), cholangitis biliary mua, a me ka sclerosing cholangitis mua.
No ke aha ʻoe e lawe ai i ka ursodeoxycholic acid (ursodiol)?
Kōkua ʻo Ursodeoxycholic acid (ursodiol) i ka pale ʻana i nā hepatocytes a me nā cholangiocytes a pale i nā pōʻino hou aʻe iā lākou. Ua hōʻike ʻia ka pauka UDCA e hoʻomaikaʻi i ke ola holoʻokoʻa o nā maʻi ma nā ʻano hepatobiliary like ʻole.
He aha ka Ursodeoxycholic Acid (UDCA) Powder?
E like me ka mea i ʻōlelo ʻia ma luna nei, ʻo Ursodeoxycholic acid powder kahi ʻano synthetic o UDCA i hoʻohana ʻia e mālama i nā maʻi e loaʻa ana i nā ʻano hepatobiliary. Uaʻikeʻia ka pauka Ursodeoxycholic acid i ka maikaʻi i ka Primary Biliary Cirrhosis a ua hōʻikeʻia e hoʻonui i ke ola o nā maʻi. No ka loaʻa ʻana o ka pauka waikawa Ursodeoxycholic maikaʻi loa a loaʻa ke kumukūʻai maikaʻi, pono paha ʻoe e kūʻai i ka pauka Ursodeoxycholic acid pauka nui.
ʻO nā waiwai kino o ka Ursodeoxycholic Acid
ʻO ka UDCA (3α, 7β-dihydroxy5β-cholanoic acid) kahi ʻakika bile lua. Hoʻokumu ʻia ia ma hope o ka hana enzymatic o nā microorganisms intestinal ma nā waikawa bile mua. ʻO nā ʻakika bile mua, ua hoʻokumu ʻia mai ka hopena hydroxylation enzymatic o ka cholesterol.
Ua hōʻike ʻia ka pauka UDCA i nā waiwai hepato-protection. ʻO ka maʻamau, ʻo ka hapa nui o nā waikawa bile mua a me ka lua i hana ʻia he hydrophobic. Ma ka ʻaoʻao ʻē aʻe, ʻo Ursodeoxycholic acid powderis hydrophilic a hoʻemi i ka pōʻino oxidative i hana ʻia e nā waikawa hydrophobic. ʻO ka waiwai hydrophilic o Ursodeoxycholic acid pauka ke kumu no ka UDCA therapy waha, he mea maʻalahi a maʻalahi.
Ma hope o ka lawe waha ʻana i ka UDCA exogenous, hiki mua ka absorption i loko o ka ʻōpū liʻiliʻi ma o ka diffusion non-ionic passive. A laila ua wāwahi ʻia ʻo UDCA i ka jejunum proximal i ka wā e hui pū ai me nā micelles o nā waikawa bile endogenous. Ma hope o kona komo ʻana i loko o ke ake, hoʻohui ʻia ka UDCA. Hoʻohui ʻia ka UDCA me ka glycine a i kahi pae liʻiliʻi me ka taurine. A laila, huna ʻia ʻo ia i loko o ka bile ma o ke kahe enterohepatic.
ʻO nā conjugates ursodeoxycholic acid i hoʻokumu ʻia e komo nui ʻia mai ka haleum distal. Hele ʻo UDCA noabsorbed i loko o ke kolonā a hoʻololi ʻia e ka maʻi bacteria o ka ʻōpū i lithocholic acid. ʻAʻole hiki ke hoʻoheheʻe ʻia ka waikawa Lithopolis a hoʻokuʻu ʻia i loko o nā feces. Hoʻopili ʻia kahi hapa liʻiliʻi o ka lithocholic acid. Hoʻopili ʻia ia i loko o ke ake, huna ʻia i loko o ka bile, a hoʻokuʻu ʻia i loko o nā feces.
Ursodeoxycholic Acid/Ursodiol Powder Mechanism of Action
Ua hōʻike ʻia ka pauka ʻo Ursodeoxycholic acid i nā hana he nui o ka hana, a aia nō nā hana i lalo o ke aʻo ʻana.
Ua hōʻike ʻia ka pauka ʻo Ursodeoxycholic acid i ka hoʻohana nui ʻana i ka pale ʻana i ka ʻeha cholangiocyte e kūʻē i nā hopena ʻawaʻawa o ka bile acids, ka hoʻoulu ʻana o ka huna biliary i hoʻopilikia ʻia ma mua, ka hoʻoulu ʻana i ke kaʻina detoxification e kūʻē i ka hydrophobic bile acids, a i ʻole ka inhibition o apoptosis, ʻo ia hoʻi, ke kelepona ponoʻī. make o nā hepatocytes.
ʻAʻole naʻe i hoʻomaopopo maikaʻi ʻia ʻo wai o kēia mau hana ke kuleana nui no nā hopena maikaʻi o UDCA. Ma waho aʻe, pili ka degere o ka pōmaikaʻi mai ka UDCA i ke kūlana kikoʻī o kēlā me kēia kanaka a me ka pae maʻi.
He aha nā kumu nui o ka pauka waikawa Ursodeoxycholic ma ka mākeke?
ʻOiai ke hana nei nā kānaka i ka UDCA, ʻoi aku ka haʻahaʻa ma mua o nā ʻakika bile ʻē aʻe i hana ʻia. No laila, ke hoʻomau nei kahi hulina ʻē aʻe. I kēia lā, ʻoi aku ka nui o ka ursodeoxycholic acid pauka i ka bea.
No ka mea aia nā kuleana holoholona a me kahi pōʻino poaching, ke nānā ʻia nei nā kumuwaiwai ʻē aʻe. Ma waena o lākou, ua hōʻike ka bovine UDCA pauka i nā hopena maikaʻi. Ke nānā ʻia nei nā kumu ʻē aʻe e like me ka hū a me ka algae. ʻO ka hana ʻana o ka UDCA mai nā molekele precursor kekahi mea hoihoi nui. Eia nō naʻe, ke noʻonoʻo ʻia nei ka hopena o ke kumukūʻai. ʻO nā mea hou loa o kēia wahi ke nānā nei i nā kumu mea kanu ma ke ʻano he ʻokoʻa. Nui nā synthetic ursodeoxycholic acid pauka no ke kūʻai aku, e ʻimi i ke kumu maoli o ka mea hoʻolako pauka ursodeoxycholic acid, pono ʻoe e nānā hou aku iā ia. A loaʻa nā mea hoʻohui ursodeoxycholic acid ma ka laina.
ʻO nā pono a me nā hopena o ka Ursodeoxycholic Acid Powder
He aha nā pōmaikaʻi o ka ursodeoxycholic acid? Ua hōʻike ka pauka UDCA i ka hoʻomaikaʻi nui a ua kaupalena ʻia i nā ʻano hepatobiliary like ʻole. Hoʻohana ʻia ia e mālama a mālama i nā ʻano hepatobiliary like ʻole, e like me nā maʻi gallstone (cholelithiasis), cholangitis biliary mua, a me ka sclerosing cholangitis.
Ua hōʻike ʻia i ka hopena maikaʻi i ka hoʻoponopono immune, hoʻohaʻahaʻa i ka cholesterol, ka hoʻoheheʻe ʻana i nā pōhaku gallbladder, pale i ke ake, a me ka hoʻohaʻahaʻa ʻana i nā pae lipid koko e inoa i kekahi. ʻOiai ʻo ka hana pololei a UDCA e hana ai pēlā he wahi o ka noiʻi ʻana, ua kūkākūkā mua ʻia nā ʻano hana i ʻike ʻia ma luna.
He aha ka Ursodeoxycholic acid pauka Hoʻohana ʻia no?
Hoʻohana nui ʻia ka ursodeoxycholic acid (ursodiol) no nā ʻano maʻi like ʻole o ka ate a me nā ducts bile. Eia naʻe, ʻaʻole i kaupalena ʻia kona hoʻohana ʻana i nā kūlana hepatobiliary wale nō. Ma o nā makahiki o ka noiʻi ikaika, ua hōʻike ʻia ka hopena maikaʻi o UDCA i ka mālama ʻana i nā ʻano like ʻole. Hoʻopili kēia i ka hoʻoheheʻe ʻana i nā pōhaku gallbladder a me ka pale ʻana a me ka mālama ʻana i nā pōhaku cholesterol. Hoʻohana pū ʻia ka pauka UDCA ma ke ʻano he mea holoi anionic no ka noiʻi biochemical, kahi anti-cholelithiasis agent, anticonvulsant, a me ka cytoprotective agent. ʻO nā hoʻohana ʻē aʻe o ka pauka ursodeoxycholic acid he wahi hoihoi i nā ʻano noiʻi e hoʻomau nei a me nā hoʻokolohua lapaʻau.
Pehea e lawe ai i ka Ursodeoxycholic Acid Powder?
ʻAʻole kūʻai pinepine ʻia ka ʻakika Ursodeoxycholic supplement ma ke keʻena kūʻai a, ʻo ka hapa nui o ka manawa e koi ʻia i ke kauka. Ma mua o ka hoʻohana ʻana i ka UDCA, he mea nui e kūkākūkā me kāu kauka i ka pilikia me ka pōmaikaʻi. Kūkākūkā pinepine ke kauka i nā laina o ka mōʻaukala olakino, ʻo ia hoʻi nā maʻi hepatobiliary a me ka mōʻaukala maʻi. ʻOiai ua hoʻohana ʻia ʻo UDCA no nā maʻi hepatobiliary, aia kekahi mau maʻi hepatobiliary kahi e pono ai ke hoʻohana ʻia.
No laila, he mea koʻikoʻi ke kūkākūkā nui me ke kauka a ʻoi aku ka nui inā loaʻa iā ʻoe kekahi moʻolelo olakino ma mua o ka laina o ascites (hui wai i loko o ka lua peritoneal), varices koko (veins e hoʻonui a kahe koko), hepatic encephalopathy (lolo. nā maʻi ma muli o ka hāʻule ʻole o ka ate), ka pōʻino o ka ate i ka wā ma mua, ka hoʻololi ʻana o ke akepaʻa, ke keʻakeʻa ʻana o ka ʻāpana biliary tract, nā pilikia ʻāpana biliary, a me ka pancreatitis.
Ke hōʻike ʻole nā kūkākūkā āpau i nā pilikia koʻikoʻi, ʻōlelo pinepine ʻia ka UDCA penei:
No ka maʻi pōhaku ʻōpū:
ʻO nā mākua a me nā keiki 12 mau makahiki a ʻoi aku—ʻO ka nui o ka waika ursodeoxycholic maʻamau he 8 a 10 milligrams (mg) no ka kilo (kg) o ke kaumaha o ke kino i kēlā me kēia lā, i māhele ʻia i ʻelua a ʻekolu paha.
Nā keiki ma lalo o 12 mau makahiki—Na ke kauka i hoʻoholo maʻamau kēia.
No ka cirrhosis biliary mua:
ʻO nā mākua—ʻO ka maʻa maʻamau he 13 a 15 milligrams (mg) no ka kilokani (kg) o ke kaumaha o ke kino i kēlā me kēia lā, i māhele ʻia i ʻelua a ʻehā mau puʻupuʻu. Hiki i kāu kauka ke hoʻololi i kāu maʻi e like me ka mea e pono ai.
Nā keiki— Na ke kauka kēia i hoʻoholo maʻamau
No ka pale ʻana i nā gallstones i ka wā o ke kaumaha wikiwiki:
ʻO nā mākua—ʻO ka nui o ka ursodeoxycholic acid he 300 milligrams (mg) ʻelua manawa i ka lā.
ʻO nā keiki ma lalo o 12 mau makahiki—Na ke kauka kēia e hoʻoholo.
ʻO ka hapa nui o ka manawa, inā ʻaʻole i hala hoʻokahi dosis, ʻo ka lawe ʻana i ka nui i hala i ka wā hiki ke ʻōlelo ʻia inā ʻaʻole ʻoi aku ka manawa mai ka hopena hope ma mua o 4 mau hola. I ka nui o na pona i hala, pono ke kukakuka me ke kauka.
Pono e lawe ʻia ʻo UDCA e pili ana i ka ʻōlelo kuhikuhi a ke kauka. I ka hihia o ka overdose, ʻaʻole hiki ke hoʻopōʻino i hoʻokahi pānaʻi ʻokoʻa. Eia nō naʻe, inā he overdose koʻikoʻi, ʻoi aku ka maikaʻi o ke kelepona ʻana i kāu kauka a i ʻole ke kipa ʻana i ka haukapila kokoke loa.
E like me kēlā me kēia lāʻau lapaʻau, loaʻa mau ka hopena ʻaoʻao i kahi degere. ʻOi aku ka maikaʻi e hoʻokaʻaʻike i kāu kauka a i ʻole ka haukapila kokoke loa inā ʻike ʻia kekahi o kēia mau hopena ʻaoʻao o ka ursodeoxycholic acid:
Nā hōʻailona maʻamau
ʻO ka ʻeha o ka ʻōpū, ka mimi koko a ʻeleʻele paha, ka ʻā a i ʻole ka ʻeha ʻana o ka mimi, ka ʻūhā, ka puʻuwai wikiwiki, ka ʻeha pinepine ʻana i ka mimi, ka ʻeha ʻana, ka ʻeha haʻahaʻa a i ʻole ka ʻaoʻao, ka nausea nui, ka ʻili a i ʻole ka ʻili ʻana ma luna o ke kino holoʻokoʻa, ʻeha ʻōpū, luaʻi, nāwaliwali.
Nā hōʻailona maʻamau liʻiliʻi
ʻEleʻele a lōʻihi ka wai, ʻeha o ka umauma, ʻaʻa a i ʻole ke kuni, ʻū, ʻike ʻia nā kiko ʻulaʻula ma ka ʻili, ʻeha nui a hoʻomau ʻia paha ka ʻōpū, ʻeha ʻāʻī a pehu paha, ʻeha a ʻeha paha a i ʻole nā kiko keʻokeʻo ma ka lehelehe a i ʻole ka waha, ke koko ʻokoʻa a i ʻole. ʻeha, luhi ʻokoʻa a nāwaliwali paha.
Ua hōʻike ʻia ka hōʻoluʻolu maʻamau o nā hōʻailona i loko o 3-6 mau pule o ka hoʻomaka ʻana i ka mālama ʻana me ka pauka UDCA. ʻOkoʻa ka lōʻihi o ke ʻano o ka lāʻau lapaʻau mai kēlā me kēia kanaka. Nānā ke kauka kuhikuhi i ke kūlana i kēlā me kēia manawa. No laila, pono ka hahai ʻana i ka manawa. Ua loaʻa palekana ka Ursodeoxycholic acid pauka i nā poʻe i lawe mau iā ia no nā mahina 6 a hiki i nā poʻe i lawe iā ia no nā mahina 48. No laila, palekana ka ʻōlelo ʻana he palekana ka pauka UDCA no ka hoʻohana lōʻihi, ke hāʻawi ʻia ka hahai ʻana i ka manawa a hana ʻia nā hoʻokolohua hana maʻamau i ka manawa.
He aha ka lāʻau lapaʻau maikaʻi loa no nā maʻi ate?
ʻAʻohe lāʻau lapaʻau maikaʻi loa a i ʻole hoʻokahi pule pana no nā maʻi ate āpau. ʻO Ursodeoxycholic acid pauka, akā, he mea pono a ʻaʻole i kaupalena ʻia i nā ʻano hepatobiliary like ʻole, e like me nā maʻi gallstone (cholelithiasis), cholangitis biliary mua, a me ka sclerosing cholangitis.
Hiki iaʻu ke lawe i ka Ursodiol/Ursodeoxycholic Acid me nā lāʻau ʻē aʻe?
ʻO UDCA kahi lāʻau palekana palekana. Eia naʻe, pono e mālama ʻia inā lawe pū ʻia kekahi mau lāʻau ʻē aʻe i loaʻa ka cholestyramine, colestimide, colestipol, alumini hydroxide, a me ka smectite me UDCA no ka mea ua hoʻopilikia ʻia ka absorption UDCA e lākou. ʻIke ʻia ka launa pū ʻana o nā lāʻau lapaʻau me nā pūhui i hoʻololi ʻia e ka cytochrome P4503A me nā lāʻau ʻē aʻe e like me cyclosporin, nitrendipine, a me dapsone.
He maikaʻi anei ka Ursodeoxycholic Acid Powder no ke ake?
ʻO ka Ursodeoxycholic Acid Powder he mea maikaʻi loa ia no ke akepaʻa ma muli o kāna mau hana pale i nā cholangiocytes a me nā hepatocytes, ka pale ʻana i ka ʻeha mai nā hopena ʻona o ka bile acids, ka hoʻoulu ʻana o ka biliary secretion, a me ka hoʻoulu ʻana i ke kaʻina detoxification e kūʻē i ka hydrophobic bile acids a me ka inhibition o apoptosis, ʻo ia hoʻi. , ka make ana o na hepatocytes ponoi.
Ua hoʻohana pū ʻia ʻo UDCA a i ʻole Udiliv (inoa kālepa) e mālama i ka maʻi ate momona, ʻoi aku ka non-alcoholic steatohepatitis (NASH), me nā hopena maikaʻi loa. Eia nō naʻe, pono nā noiʻi hou aʻe a me nā meta-analyses no ka pono maoli.
He aha nā ʻokoʻa ma waena o Ursodeoxycholic Acid (UDCA) a me Chenodeoxycholic Acid (CDCA)?
ʻO ka UDCA a me ka CDCA he mau waika bile. I loko o ke kanaka, hana ʻia ʻo UDCA a me Chenodeoxycholic Acid (CDCA). Eia naʻe, hoʻopuka ʻia ka CDCA ma nā huina nui loa. ʻO ka UDCA a me ka CDCA nā huahana hōʻemi o ka cholesterol, e hoʻomaka me. ʻO ka CDCA kahi waika bile mua, ʻo ia hoʻi, ua hoʻohui ʻia e ke ake mai ka cholesterol, ʻoiai ua hana ʻia ʻo UDCA ma muli o ka haki ʻana o ka enzymatic e ka bacteria i loko o ka ʻōpū.
No laila, i loko o ka pōʻaiapili o ka maʻi ʻāʻī, ʻoi aku ka maikaʻi o ka Ursodeoxycholic Acid (UDCA) ma mua o ka CDCA ma nā papa haʻahaʻa a kiʻekiʻe.
Buy Ursodeoxycholic Acid pauda nui? | kahi e imi i ka maikai Ursodeoxycholic Acid mea hana pauda?
Hiki ke kūʻai ʻia ʻo Ursodeoxycholic acid powder bulk ma ka pūnaewele ma o nā pūnaewele like ʻole. Eia naʻe, pono ʻoe e makaʻala e pili ana i ka ʻoiaʻiʻo a me ka maikaʻi o ka huahana. Pono e hana mua ʻia kahi nānā kikoʻī o nā mea hana a me ka noʻonoʻo. ʻO Phcoker ka mea hana ursodeoxycholic acid pauka maikaʻi loa.
Ursodeoxycholic Acid: ʻO ke alakaʻi FAQ hope loa
He hana maoli anei ka ursodiol?
ʻAe. Ua hōʻike ʻia ka maikaʻi o Ursodiol i ka mālama ʻana i nā maʻi hepatobiliary like ʻole, inā loaʻa kahi maʻi maʻi mua, a hoʻomaka ka mālama ʻana i ka wā hiki.
He aha ka lāʻau e hoʻoheheʻe ai i ka gallbladder sludge?
Ua hōʻoia ʻia ka pauka UDCA i ka hoʻoheheʻe ʻana i ka ʻōpala gallbladder.
Hiki i ka ursodiol ke hoʻonui i ke kaumaha?
Hiki i ka pauka UDCA ke hoʻonui i ke kaumaha, ʻoi aku hoʻi i nā mahina 12 mua o ka mālama ʻana.
He steroid anei ka ursodiol?
Hoʻokaʻawale ʻia nā steroid o nā ʻano like ʻole. Hoʻohui ʻia nā steroid a me nā waikawa bile a i ʻole nā huahana metabolic o ka cholesterol. Ua hōʻike kekahi mau haʻawina i ke ʻano like me ka steroid o nā ʻakika bile i ka hoʻoponopono ʻana i nā hana kino o kēlā me kēia lā. Eia nō naʻe, pono nā noiʻi hou aʻe ma ke kahua no nā hōʻike paʻa.
He immunosuppressant anei ka ursodiol?
Ua loaʻa iā UDCA kekahi mau waiwai immunosuppressant.
Ua hoʻohaʻahaʻa anei ʻo ursodiol i nā ʻakika bile?
Ua hōʻike ʻo UDCA i ka maikaʻi i ka hoʻoulu ʻana i ka detoxification e kūʻē i nā waikawa hydrophobic. Ua hōʻike pū ʻia ka pauka ʻo Ursodeoxycholic acid e hōʻemi i nā waikawa hydrophobic. Eia naʻe, pono mau ka noiʻi hou ʻana.
Hoʻomaikaʻi anei ʻo ursodiol i nā enzyme ate?
Ua hōʻoia ʻia ʻo UDCA i ka hoʻomaikaʻi ʻana i nā enzymes o ka ate i nā ʻano maʻi o ka ate.
ʻO ka ursodeoxycholic acid ka lehu maikaʻi no ka puʻupaʻa?
ʻO ka noiʻi ʻana i nā ʻiole i hōʻike ʻole i ka pōʻino e ka pauka UDCA. Eia naʻe, ke hoʻomau nei ka noiʻi nui ʻana i ke kanaka.
Hiki i ka ursodiol ke kōkua i ka momona momona?
Pono ka UDCA i ka momona momona. Eia naʻe, ke hoʻomau nei nā hoʻokolohua i hoʻolālā ʻia no ke kumuhana like.
Ua emi anei ka ursodiol i ka triglycerides?
Ua ʻike ʻia ʻo UDCA e hoʻohaʻahaʻa i nā lipoproteins haʻahaʻa haʻahaʻa (LDL) a me nā lipoproteins haʻahaʻa haʻahaʻa loa (VLDL). Eia naʻe, ʻaʻohe loli koʻikoʻi o ka pae triglyceride ma hope o ka mālama ʻana me ka pauka UDCA.
Aia kekahi mea ʻē aʻe i ka ursodiol?
Aia kekahi lāʻau lapaʻau ʻē aʻe i ka UDCA. Eia nō naʻe, ua hoʻopaʻapaʻa ka maikaʻi a me ka maikaʻi o kēlā mau mea hana. He mea kōkua ke kamaʻilio ʻana i ke kauka e pili ana i ke ala a me ka mea maikaʻi loa iā ʻoe.
He lāʻau lāʻau ʻo ursocol?
ʻAʻole, ʻaʻole he antibiotic ka ursocol. He lāʻau ia me nā hana like ʻole akā pale mua i nā hepatocytes a kōkua i ka haki ʻana o nā gallstones.
He ma'i ate anei ka cholestasis?
ʻO Cholestasis ke ʻano o ka pau ʻana o ke kahe ʻana o ka bile ma ka lāʻau biliary a i ʻole ke kahe ʻana. Hiki i kēia keakea i ke kahe o ka bile ke hōʻeha i ka ate a me nā maʻi.
Pehea ka maikaʻi o ka ursodeoxycholic acid?
He kūpono ka UDCA i ka mālama ʻana i nā maʻi hepatobiliary a me nā kūlana ʻē aʻe.
He aha ke ʻano o ka lāʻau ursodiol?
ʻO ka UDCA kahi waikawa bile lua. He mea maikaʻi loa ia i ka pale ʻana i ka ʻeha cholangiocyte e kūʻē i nā hopena ʻawaʻawa o ka bile acid, ka hoʻoulu ʻana o ka biliary secretion i hoʻopilikia ʻia ma mua, ka hoʻoulu ʻana i ke kaʻina detoxification e kūʻē i nā waikawa bile hydrophobic, a i ʻole ka inhibition o ka apoptosis ʻo ia hoʻi, ka make ʻana o nā hepatocytes ponoʻī.
Ua hoʻohaʻahaʻa anei ʻo Ursodiol i ka cholesterol?
Hōʻike nā haʻawina e hiki i ka pauka ʻo Ursodeoxycholic acid ke hoʻemi i nā pae cholesterol.
Hiki i ka ursodiol ke hana i ka pancreatitis?
ʻAʻole maʻamau ka pancreatitis me ka hoʻohana ʻana i ka UDCA. Ua hoʻohana ʻia ʻo UDCA no ka mālama ʻana i ka pancreatitis.
Ua hiamoe anei ka ursodiol?
ʻO ka luhi a me ka nāwaliwali kekahi o nā hopena ʻaoʻao maʻamau o UDCA.
E hoʻomaopopo '
- Hoʻohana i ka ursodeoxycholic acid i nā maʻi ate. D Kumar, RK Tandon.J Gastroenterol Hepatol. 2001 Jan;16(1):3-14. doi: 10.1046/j.1440-1746.2001.02376.x.PMID: 11206313
- ʻO ka Ursodeoxycholic acid i ka maʻi o ka ate cholestatic: nā hana o ka hana a me ka hoʻohana therapeutic i nānā hou ʻia.Gustav Paumgartner, Ulrich Beuers.PMID: 12198643 DOI: 10.1053 / jhep.2002.36088 Hepatology. 2002 Sep;36(3):525-31.
- Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease.Gustav Paumgartner, Ulrich Beuers.PMID: 15062194 DOI: 10.1016 / S1089-3261(03)00135-1 Clin Liver Dis. 2004 Feb;8(1):67-81, vi.
- Ka Manaʻo o ka Bile Acids Hōʻailona a me ka Manaʻo ma ka hōʻailona o ka Ursodeoxycholic Acid, ka waiʻawaʻawa nui loa o ka hydrophilic, i loko o ka naʻau.Noorul Izzati Hanafi, Anis Syamimi Mohamed, Siti Hamimah Sheikh Abdul Kadir, Mohd Hafiz Dzarfan Othman.PMID: 30486474 PMCID: PMCID: PMC6316857 : 10.3390/biom8040159 Biomolele. 2018 Nov 27;8(4):159.
- ʻO ka pane Ursodeoxycholic Acid e pili ana me ka emi ʻana o ka make ma ka Primary Biliary Cholangitis me ka Cirrhosis i uku ʻia. Binu V John, Nidah S Khakoo, Kaley B Schwartz, Gabriella Aitchenson, Cynthia Levy, Bassam Dahman, Yangyang Deng, David S Goldberg, Paul Martin, David E Kaplan , Tamar H Taddei.PMID: 33989225 PMCID: PMC8410631 (loa'a ma 2022-09-01) DOI: 10.14309/ajg.0000000000001280 Am J Gastroenterol. 2021 Sep 1;116(9):1913-1923.
- He aha ka mana o ka ursodeoxycholic acid therapy lōʻihi i nā poʻe maʻi me ka cirrhosis biliary mua?Virginia C Clark, Cynthia Levy.PMID: 17290236 DOI: 10.1038/ncpgasthep0741 Nat Clin Pract Gastroenterol Hepatol. 2007 Apr;4(4):188-9.
- Hoʻomohala hou i ka synthesis o ka ursodeoxycholic acid (UDCA): kahi loiloi koʻikoʻi. Fabio Tonin a me Isabel WCE Arends ka mea kākau.PMCID: PMC5827811 PMID: 29520309 doi: 10.3762/bjoc.14.33 Beilstein J Org Chem. 2018; 14:470–483.
- Bear bile: pilikia o ka hoʻohana lāʻau kuʻuna a me ka pale holoholona. ʻO Yibin Feng, ka mea kākau pili ʻo Kayu Siu, Ning Wang, Kwan-Ming Ng, Sai-Wah Tsao, Tadashi Nagamatsu, a me Yao Tong.PMCID: PMC2630947 PMID: 19138420 doi: 10.1186/1746-4269-5-2 Enomthnobiolth. 2009; 5:2.
- ʻO ka waikawa Ursodeoxycholic: he mea palekana a maikaʻi hoʻi no ka hoʻopau ʻana i nā pōhaku cholesterol.GS Tint, G Salen, A Colalillo, D Graber, D Verga, J Speck, S Shefer.PMID: 7051912 doi: 10.7326/0003-4819-97-3-351 . Ann Intern Med. 1982 Sep;97(3):351-6.
- ʻO ka lāʻau hoʻoheheʻe ʻia ʻo Gallstone me ka ursodiol. Ka pono a me ka palekana. G Salen.PMID: 2689115 DOI: 10.1007/BF01536661 Eli Dis Sci. 1989 Dec;34(12 Suppl):39S-43S.
- ʻO Ursodeoxycholic acid - nā hopena ʻino a me nā pilina lāʻau. Hempfling, K. Dilger,U. Beuers
- ʻO ka waikawa Ursodeoxycholic no ka mālamaʻana i ka steatohepatitis nona ka waiʻona: Nā hualoaʻa o kahi ho'āʻo randomized. Keith D. Lindor, Kris V. Kowdley, E. Jenny Heathcote,M. Edwyn Harrison, Roberta Jorgensen, Paul Angulo, James F. Lymp, Lawrence Burgart, Patrick Colin
- ʻO ka lāʻau ursodeoxycholic acid kiʻekiʻe no ka steatohepatitis nona ka waiʻona: kahi hoʻāʻo ʻelua makapō, randomized, placebo-controlled trial†.Ulrich FH Leuschner,Birgit Lindenthal,Günter Herrmann,Joachim C. Arnold,Martin Rössle,Hans-Jörg Cordes,Stefan Zeuzem,Jasper Zeuzem Hein, Thomas Berg, ka NASH Study Group
- ʻO ka waikawa Ursodeoxycholic no ka mālamaʻana i ka steatohepatitis nona ka waiʻona: Nā hualoaʻa o kahi ho'āʻo randomized. Keith D. Lindor, Kris V. Kowdley, E. Jenny Heathcote,M. Edwyn Harrison, Roberta Jorgensen, Paul Angulo, James F. Lymp, Lawrence Burgart, Patrick Colin
- ʻO ke kuleana o ka ursodeoxycholic acid i loko o ka steatohepatitis non-alcoholic: kahi loiloi systematic.Zun Xiang, Yi-peng Chen, Kui-fen Ma, Yue-fang Ye, Lin Zheng, Yi-da Yang, You-ming Li, Xi Jin.PMID : 24053454 PMCID: PMC3848865 DOI: 10.1186/1471-230X-13-140 BMC Gastroenterol. 2013 Sep 23;13:140.
- Ursodeoxycholic acid vs. chenodeoxycholic acid like cholesterol gallstone-dissolving agents: he comparative randomized study.E Roda, F Bazzoli, AM Labate, G Mazzella, A Roda, C Sama, D Festi, R Aldini, F Taroni, L Barbara.PMID: 7141392 DOI: 10.1002/hep.1840020611 Hepatology. Nov-Dek 1982;2(6):804-10.
